Central Nervous System Targeted Protein Degraders
نویسندگان
چکیده
Diseases of the central nervous system, which once occupied a large component pharmaceutical industry research and development portfolio, have for many years played smaller part in major pharma pipelines—primarily due to well cited challenges target validation, valid translational models, clinical trial design. Unfortunately, this decline interest has occurred tandem with an increase medical need—in driven by success treating other chronic diseases, then results greater overall longevity along higher prevalence diseases associated ageing. The lead modality drug agents targeting brain remains traditionally small molecule, despite potential gene-based therapies antibodies, particularly hugely anticipated anti-amyloid field, clearly additional challenge effective distribution relevant compartments. However, recognition growing disease burden, advanced are being developed improved delivery options. Hence, methodologies were initially restricted systemic indications now actively explored range CNS diseases—an important class include protein degradation technologies.
منابع مشابه
ADENOSINE IN THE CENTRAL NERVOUS SYSTEM
Besides being a metabolite of nucleotides like ATP, adenosine is a mediator of neuronal function in the central nervous system. Its actions are mediated by at least three extracellular receptors. In this review different aspects of adenosine such as biosynthesis, release, inactivation and its receptors are discussed. It also covers pre- and postsynaptic effects as well as postreceptor mecha...
متن کاملP124: Listeriosis in Central Nervous System
Listeriosis is one of the CNS inflammatory diseases which is happened majority in the form of sporadic. Listeriosis is ingested with the food. Infection occurrence in an exposed person depends on the number of organisms ingested, the virulence of the organisms strain and the individual condition. It is known that Listeriosis has decisive importance as an infection which the cellular immunodefen...
متن کاملHYPERVITAMINOSIS A-INDUCED CENTRAL NERVOUS SYSTEM DEFECTS
In this investigation the effects of excess vitamin A administration during the early embryonic period were studied. Intramuscular injection of a single dose of 15000,20000 or 25000 IU/kg vitamin A to pregnant Balb/c strain mice on either day 7,8,9 or 10 of gestation (vaginal plug= day 0 of gestation) produced major malformations in the central nervous system (CNS) including exencephaly, h...
متن کاملGene-targeted therapies for the central nervous system.
T he identification of the genes and proteins involved in many neurodegenerative diseases offers the exciting possibility of modifying those disease-linked proteins to develop novel, targeted therapies for diseases such as amyotrophic lateral sclerosis (ALS) or Huntington disease. In many of these diseases, the simplest modification— decreasing the amount of the offending protein—may represent ...
متن کاملprimary central nervous system lymphoma
objective primary central nervous system lymphoma (pcnsl) is an extremely rare condition in childhood. we report the first case of pcnsl in a child in iran. clinical presentation a nine-year-old boy was referred to mofid hospital with the history of headache of four months and seizure of 2 months duration. magnetic resonance imaging of the brain revealed a hyper-intense lesion in left fronto-pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomolecules
سال: 2023
ISSN: ['2218-273X']
DOI: https://doi.org/10.3390/biom13081164